Biktarvy, formally known as bictegravir, represents a potent single-tablet therapy for managing HIV infection. This formula combines three key antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by inhibiting the the viral ability to multiply within the body, significantly lowering the viral load. For many individu